Ryman Healthcare Limited
RHCGF · OTC
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Market Cap | $1,762,813 | $3,867,746 | $2,805,637 | $4,918,078 |
| - Cash | $17,658 | $41,809 | $27,879 | $28,309 |
| + Debt | $1,695,264 | $2,569,064 | $2,344,737 | $2,590,231 |
| Enterprise Value | $3,440,419 | $6,395,001 | $5,122,495 | $7,480,000 |
| Revenue | $713,797 | $650,534 | $560,110 | $503,758 |
| % Growth | 9.7% | 16.1% | 11.2% | – |
| Gross Profit | $713,797 | -$1,349 | -$19,766 | $1,822 |
| % Margin | 100% | -0.2% | -3.5% | 0.4% |
| EBITDA | -$27,155 | -$50,730 | $457,980 | $788,242 |
| % Margin | -3.8% | -7.8% | 81.8% | 156.5% |
| Net Income | -$436,831 | $4,775 | $257,836 | $692,873 |
| % Margin | -61.2% | 0.7% | 46% | 137.5% |
| EPS Diluted | -0.61 | 0.007 | 0.5 | 1.31 |
| % Growth | -8,940.6% | -98.6% | -61.8% | – |
| Operating Cash Flow | $410,250 | $658,482 | $542,760 | $535,972 |
| Capital Expenditures | -$107,360 | -$172,199 | -$324,206 | -$298,634 |
| Free Cash Flow | $302,890 | $486,283 | $218,554 | $237,338 |